Загрузка...

Beneficial Effect of Oral Bisphosphonate Treatment on Bone Loss Induced by Chronic Administration of Furosemide without Alteration of Its Administration and Urinary Calcium Loss

Bisphosphonate is widely used to treat patients with primary and secondary osteoporosis. The chronic administration of furosemide is considered a risk factor for osteoporosis mainly due to the increased urinary excretion of calcium, leading to a long-term negative balance of calcium. We describe two...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Kubota, Takuo, Namba, Noriyuki, Kurotobi, Shunji, Kogaki, Shigetoyo, Hirai, Haruhiko, Kitaoka, Taichi, Nakajima, Shigeo, Ozono, Keiichi
Формат: Artigo
Язык:Inglês
Опубликовано: The Japanese Society for Pediatric Endocrinology 2006
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4004841/
https://ncbi.nlm.nih.gov/pubmed/24790329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1297/cpe.15.101
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!